[HTML][HTML] BamQuery: a proteogenomic tool to explore the immunopeptidome and prioritize actionable tumor antigens

MVR Cuevas, MP Hardy, JD Larouche, A Apavaloaei… - Genome Biology, 2023 - Springer
MVR Cuevas, MP Hardy, JD Larouche, A Apavaloaei, E Kina, K Vincent, P Gendron…
Genome Biology, 2023Springer
MHC-I-associated peptides deriving from non-coding genomic regions and mutations can
generate tumor-specific antigens, including neoantigens. Quantifying tumor-specific
antigens' RNA expression in malignant and benign tissues is critical for discriminating
actionable targets. We present BamQuery, a tool attributing an exhaustive RNA expression
to MHC-I-associated peptides of any origin from bulk and single-cell RNA-sequencing data.
We show that many cryptic and mutated tumor-specific antigens can derive from multiple …
Abstract
MHC-I-associated peptides deriving from non-coding genomic regions and mutations can generate tumor-specific antigens, including neoantigens. Quantifying tumor-specific antigens’ RNA expression in malignant and benign tissues is critical for discriminating actionable targets. We present BamQuery, a tool attributing an exhaustive RNA expression to MHC-I-associated peptides of any origin from bulk and single-cell RNA-sequencing data. We show that many cryptic and mutated tumor-specific antigens can derive from multiple discrete genomic regions, abundantly expressed in normal tissues. BamQuery can also be used to predict MHC-I-associated peptides immunogenicity and identify actionable tumor-specific antigens de novo.
Springer